4//SEC Filing
SACHS BRUCE I 4
Accession 0000875320-24-000200
CIK 0000875320other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:10 PM ET
Size
8.1 KB
Accession
0000875320-24-000200
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Sale
Common Stock
2024-08-01$508.00/sh−5,295$2,689,860→ 40,000 total - Exercise/Conversion
Common Stock
2024-08-01$125.71/sh+5,295$665,634→ 45,295 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-01−5,295→ 0 totalExercise: $125.71Exp: 2027-05-31→ Common Stock (5,295 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001197036
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:10 PM ET
- Size
- 8.1 KB